Unknown

Dataset Information

0

Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG29 and Pluronic® P85 unimers.

ABSTRACT: Pneumococcal meningitis (PM), caused by Streptococcus pneumonia, remains a high-burden disease in developing countries. Antibiotic therapy has been limited due to the inefficiency of drug transport across the blood-brain barrier (BBB) and the emergence of drug-resistant strains. In our preliminary study, PEGylated nano-self-assemblies of bacitracin A (PEGylated Nano-BA12K) demonstrated a strong antibacterial potency against S. pneumonia. In this study, the potential application of this micelle for the treatment of both Penicillin-sensitive and -resistant PM was studied. To address BBB-targeting and -crossing issues, PEGylated Nano-BA12K was formulated with a specific brain-targeting peptide (rabies virus glycopeptide-29, RVG29) and a P-glycoprotein inhibitor (Pluronic® P85 unimers) to construct a mixed micellar system (RVG29-Nano-BAP85). RVG29-Nano-BAP85 demonstrated a strong antibacterial potency against 13 clinical isolates of S. pneumonia, even higher than that of Penicillin G, a conventional anti-PM agent. RVG29-Nano-BAP85 had more cellular uptake in brain capillary endothelial cells (BCECs) and higher BBB-crossing efficiency than single formulated Nano-BAs as shown in an in vitro BBB model. The enhanced BBB-permeability was attributed to the synergetic effect of RVG29 and P85 unimers through receptor-mediated transcytosis, exhaustion of ATP, and reduction in membrane microviscosity. In vivo results further demonstrated that RVG29-Nano-BAP85 was able to accumulate in brain parenchyma as confirmed by in vivo optical imaging. In addition, RVG29-Nano-BAP85 exhibited high therapeutic efficiencies in both Penicillin-sensitive and -resistant PM mouse models with negligible systemic toxicity. Collectively, RVG29-Nano-BAP85 could effectively overcome BBB barriers and suppressed the growth of both drug-sensitive and -resistant S. pneumonia in the brain tissues, which demonstrated its potential for the treatment of PM.

SUBMITTER: Hong W 

PROVIDER: S-EPMC6225518 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.
| S-EPMC2644348 | biostudies-literature
Unknown Tetrahedral (<i>T</i>) Closed-Shell Cluster of 29 Silver Atoms & 12 Lipoate Ligands, [Ag<sub>29</sub>(R-α-LA)<sub>12</sub>]<sup>(3-)</sup>: Antibacterial and Antifungal Activity.
| S-EPMC7523820 | biostudies-literature
Unknown A comparison of <sup>64</sup>Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin α<sub>ν</sub>β<sub>6</sub>.
| S-EPMC8849274 | biostudies-literature
Unknown Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles.
| S-EPMC4750032 | biostudies-literature
Unknown The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells.
| S-EPMC2667955 | biostudies-literature
Unknown Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.
| S-EPMC2566789 | biostudies-literature
Unknown Cyclic RGD-conjugated Pluronic<sup>®</sup> blending system for active, targeted drug delivery.
| S-EPMC6091488 | biostudies-literature
Unknown Pluronic-based nano-self-assemblies of bacitracin A with a new mechanism of action for an efficient in vivo therapeutic effect against bacterial peritonitis.
| S-EPMC6131780 | biostudies-literature
Unknown sEVs<sup>RVG</sup> selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model.
| S-EPMC9092305 | biostudies-literature
Unknown Periodic Trends Manifested through Gas-Phase Generation of Anions Such as [AlH<sub>4</sub>]<sup>-</sup>, [GaH<sub>4</sub>]<sup>-</sup>, [InH<sub>4</sub>]<sup>-</sup>, [SrH<sub>3</sub>]<sup>-</sup>, [BaH<sub>3</sub>]<sup>-</sup>, [Ba(0)(η<sup>2</sup>-O<sub>2</sub>CH)<sub>1</sub>]<sup>-</sup>, [Pb(0)H]<sup>-</sup>, [Bi(I)H<sub>2</sub>]<sup>-</sup>, and Bi<sup>-</sup> from Formates.
| S-EPMC6641263 | biostudies-literature